Correlation Between Quantitative and Health Biotchnology
Can any of the company-specific risk be diversified away by investing in both Quantitative and Health Biotchnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Quantitative and Health Biotchnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Quantitative Longshort Equity and Health Biotchnology Portfolio, you can compare the effects of market volatilities on Quantitative and Health Biotchnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Quantitative with a short position of Health Biotchnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Quantitative and Health Biotchnology.
Diversification Opportunities for Quantitative and Health Biotchnology
0.54 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Quantitative and Health is 0.54. Overlapping area represents the amount of risk that can be diversified away by holding Quantitative Longshort Equity and Health Biotchnology Portfolio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Health Biotchnology and Quantitative is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Quantitative Longshort Equity are associated (or correlated) with Health Biotchnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Health Biotchnology has no effect on the direction of Quantitative i.e., Quantitative and Health Biotchnology go up and down completely randomly.
Pair Corralation between Quantitative and Health Biotchnology
Assuming the 90 days horizon Quantitative Longshort Equity is expected to under-perform the Health Biotchnology. But the mutual fund apears to be less risky and, when comparing its historical volatility, Quantitative Longshort Equity is 2.11 times less risky than Health Biotchnology. The mutual fund trades about -0.23 of its potential returns per unit of risk. The Health Biotchnology Portfolio is currently generating about -0.04 of returns per unit of risk over similar time horizon. If you would invest 2,392 in Health Biotchnology Portfolio on December 4, 2024 and sell it today you would lose (19.00) from holding Health Biotchnology Portfolio or give up 0.79% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Quantitative Longshort Equity vs. Health Biotchnology Portfolio
Performance |
Timeline |
Quantitative Longshort |
Health Biotchnology |
Quantitative and Health Biotchnology Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Quantitative and Health Biotchnology
The main advantage of trading using opposite Quantitative and Health Biotchnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Quantitative position performs unexpectedly, Health Biotchnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Health Biotchnology will offset losses from the drop in Health Biotchnology's long position.Quantitative vs. Virtus Multi Sector Short | Quantitative vs. Calvert Short Duration | Quantitative vs. Cmg Ultra Short | Quantitative vs. Prudential Short Duration |
Health Biotchnology vs. Nuveen Nwq Small Cap | Health Biotchnology vs. Boston Partners Small | Health Biotchnology vs. T Rowe Price | Health Biotchnology vs. Ashmore Emerging Markets |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |